(Q42201346)

18 October 2017

title

Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples (English)

1 reference

18 October 2017

main subject

cervix uterine cancer

1 reference

Jijgee Munkhdelger

1

1 reference

18 October 2017

Geehyuk Kim

2

1 reference

18 October 2017

Hye-young Wang

3

1 reference

18 October 2017

Dongsup Lee

4

1 reference

18 October 2017

Sunghyun Kim

5

1 reference

18 October 2017

Yeonim Choi

6

1 reference

18 October 2017

Eunhee Choi

7

1 reference

18 October 2017

Sunyoung Park

8

1 reference

18 October 2017

Hyunwoo Jin

9

1 reference

18 October 2017

Kwang Hwa Park

10

1 reference

18 October 2017

Hyeyoung Lee

11

1 reference

18 October 2017

publication date

4 August 2014

1 reference

Experimental and Molecular Pathology

18 October 2017

published in

1 reference

18 October 2017

volume

97

1 reference

18 October 2017

issue

2

1 reference

18 October 2017

page(s)

279-284

1 reference

Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients.

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

REBA HPV-ID® for efficient genotyping of human papillomavirus in clinical samples from Korean patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Human papillomavirus infection and cervical cancer prevention in Japan and Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.004

10.1016/J.YEXMP.2014.08.004

7 January 2021

Identifiers

DOI

1 reference

18 October 2017

1 reference